• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 6-K filed by TIAN RUIXIANG Holdings Ltd

    2/18/26 12:10:12 PM ET
    $TIRX
    Specialty Insurers
    Finance
    Get the next $TIRX alert in real time by email
    6-K 1 tm266721d1_6k.htm FORM 6-K

     

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

    FORM 6-K

     

    REPORT OF FOREIGN PRIVATE ISSUER

    PURSUANT TO RULE 13a-16 OR 15d-16

    UNDER THE SECURITIES EXCHANGE ACT OF 1934

     

    For the month of February 2026

     

    Commission File Number: 001- 39925

     

    TIAN RUIXIANG Holdings Ltd

     

    2107, Block B, Shoudong International

    Dongcheng District, Beijing

    People’s Republic of China

    (Address of principal executive offices)

     

    Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

     

    Form 20-F x       Form 40-F ¨

     

     

     

     

     

     

    Results of TIAN RUIXIANG Holdings Ltd.'s Annual General Meeting of Shareholders on February 17, 2026

     

    An Annual General Meeting of Shareholders (the “Meeting”) of TIAN RUIXIANG Holdings Ltd. (the “Company”) was held at 2107, Block B, Shoudong International, Dongcheng District, Beijing, People’s Republic of China on February 17, 2027, at 10:00 a.m. Beijing Time, pursuant to notice duly given.

     

    At the close of business on January 21, 2026, the record date for the determination of shareholders of the Company entitled to vote at the Meeting, there were 43,603,573 shares of Class A ordinary shares (each share being entitled to one (1) vote), and 210,000 shares of Class B ordinary shares outstanding (each share being entitled to six hundred (600) votes). At the Meeting, the holders of (1) 39,388,370.31 shares of Class A ordinary Shares, and (2) 210,000 shares of Class B ordinary shares, representing a total of 165,388,370.31 votes, were represented in person or by proxy, constituting a quorum.

     

    The shareholders adopted the following resolutions (the “Resolutions”) at the Meeting:

     

    1.Share Capital Increase: Resolved, as an ordinary resolution, that with immediate effect, the authorised share capital of the Company be increased from US$200,000,000 consisting of 1,600,000,000 shares comprising of (i) 1,520,000,000 class A ordinary shares of a par value of US$0.125 each, and (ii) 80,000,000 class B ordinary shares of a par value of US$0.125 each, to US$3,750,000,000 consisting of 30,000,000,000 shares comprising of (i) 1,520,000,000 Class A Ordinary Shares of a par value of US$0.125 each, and (ii) 28,480,000,000 Class B Ordinary Shares of a par value of US$0.125 each.

     

    2.Amendment of the M&A: Resolved, a s a special resolution, that conditional upon the approval of the Share Capital Increase and to reflect the Share Capital Increase: The first sentence of paragraph 8 of the currently effective memorandum of association of the Company be amended and restated in its entirety to read as follows (the "Amendment of the M&A"): 'The authorised share capital of the Company is US$3,750,000,000 consisting of 30,000,000,000 shares comprising of (i) 1,520,000,000 Class A Ordinary Shares of a par value of US$0.125 each, and (ii) 28,480,000,000 Class B Ordinary Shares of a par value of US$0.125 each.'"

     

    3.Board Reverse Split Authority: Resolved, as an ordinary resolution, that conditional upon the approval of the Board of Directors in its sole discretion, with effect as of the date the Board of Directors may determine: (i) all of the authorized, issued and outstanding shares of the Company (collectively, the “Shares”) be consolidated, at any one time or multiple times within a period of three (3) years from the date of the Meeting, at the exact consolidation ratio and effective time as the Board of Directors may determine in its sole discretion, provided always that the accumulated consolidation ratio for all such share consolidation(s) (together, the “Authorized Share Consolidations”, and each an “Authorized Share Consolidation”) shall not be less than 2:1 nor greater than 5,000:1, with such consolidated Shares having the same rights and being subject to the same restrictions (save as to par value) as the existing Shares of such class as set out in the Company’s then effective memorandum and articles of association; (ii) no fractional Shares be issued in connection with the Authorized Share Consolidation(s) and, in the event that a shareholder would otherwise be entitled to receive a fractional Share upon an Authorized Share Consolidation, the total number of Shares to be received by such shareholder be rounded up to the next whole Share; and (iii) any change to the Company’s authorized share capital in connection with, and as necessary to effect, the Authorized Share Consolidation(s), be and is hereby approved, such amendment to be determined by the Board of Directors in its sole discretion; and any one director or officer of the Company be and is hereby authorised, for and on behalf of the Company, to do all such other acts or things necessary or desirable to implement, carry out, and give effect to the Board Reverse Split Authority and Authorized Share Consolidations.

     

    4.Further Amendment of the M&A: Resolved, as a special resolution, subject to and immediately following an Authorized Share Consolidation being effected, the Company adopt an amended and restated memorandum and articles of association in substitution for, and to the entire exclusion of, the Company’s then existing amended and restated memorandum and articles of association, to reflect the relevant Authorized Share Consolidation upon its effectiveness.

     

     

     

     

    At the Meeting, the Votes for the Resolutions were as follows:

     

    PROPOSAL   Class of   FOR  AGAINST  ABSTAIN/WITHHOLD 
          Issue   Shares Voted  Voting Power  % of O/S Shares  % of Votes
    Cast
      Shares Voted  Voting Power  of O/S Shar  % of Votes
    Cast
      Shares Voted  Voting Power  of O/S Shar  % of Votes
    Cast
     

     

      Class A    39,361,429.01   39,361,429.01   90.27%  99.93%  26,936.20   26,936.20   0.06%  0.07%  5.10   5.10   0.00%  0.00%
    Proposal 1  Share Capital Increase   Class B    210,000.00   126,000,000.00   100.00%  100.00%  0.00   0.00   0.00%  0.00%  0.00   0.00   0.00%  0.00%
          Total    39,571,429.01   165,361,429.01   90.32%  99.98%  26,936.20   26,936.20   0.06%  0.02%  5.10   5.10   0.00%  0.00%
                                                             

     

        Class A    39,361,563.51   39,361,563.51   90.27%  99.93%  26,701.20   26,701.20   0.06%  0.07%  105.60   105.60   0.00%  0.00%
    Proposal 2 Amendment of the M&A   Class B    210,000.00   126,000,000.00   100.00%  100.00%  0.00   0.00   0.00%  0.00%  0.00   0.00   0.00%  0.00%
          Total    39,571,563.51   165,361,563.51   90.32%  99.98%  26,701.20   26,701.20   0.06%  0.02%  105.60   105.60   0.00%  0.00%
                                                             

     

      Class A    39,360,351.71   39,360,351.71   90.27%  99.93%  27,130.00   27,130.00   0.06%  0.07%  888.60   888.60   0.00%  0.00%
    Proposal 3 Board Reverse Split Authority   Class B    210,000.00   126,000,000.00   100.00%  100.00%  0.00   0.00   0.00%  0.00%  0.00   0.00   0.00%  0.00%
          Total    39,570,351.71   165,360,351.71   90.32%  99.98%  27,130.00   27,130.00   0.06%  0.02%  888.60   888.60   0.00%  0.00%
                                                             

     

      Class A    39,361,359.71   39,361,359.71   90.27%  99.93%  26,800.70   26,800.70   0.06%  0.07%  209.90   209.90   0.00%  0.00%
    Proposal 4 Further Amendment of the M&A   Class B    210,000.00   126,000,000.00   100.00%  100.00%  0.00   0.00   0.00%  0.00%  0.00   0.00   0.00%  0.00%
          Total    39,571,359.71   165,361,359.71   90.32%  99.98%  26,800.70   26,800.70   0.06%  0.02%  209.90   209.90   0.00%  0.00%

     

    On February 17, 2026, following the authority granted by the shareholders at the Meeting, the Board of Directors of the Company approved a reverse split of all of the Company’s authorized and issued Class A ordinary shares and Class B ordinary shares at a ratio of one-for-fifty (1-for-50) (the “Reverse Stock Split”).

     

    The Company expects the Reverse Stock Split to become effective for trading purposes on the Nasdaq Capital Market (“Nasdaq”) in or about early March 2026, pending final processing by Nasdaq. The Company’s Class A ordinary shares will continue to trade under the symbol “TIRX”. A new CUSIP number will be assigned to the Class A ordinary shares in connection with the Reverse Stock Split and will be disclosed once finalized.

     

     

     

     

    EXHIBIT INDEX

     

    Exhibit No.   Description
    99.1   Press Release dated February 18, 2026 

     

     

     

     

    SIGNATURES

     

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

     

      TIAN RUIXIANG Holdings Ltd
         
    Date: February 18, 2026 By: /s/ Baohai Xu
      Name: Baohai Xu
      Title: Chief Executive Officer

     

     

     

    Get the next $TIRX alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $TIRX

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $TIRX
    SEC Filings

    View All

    SEC Form 6-K filed by TIAN RUIXIANG Holdings Ltd

    6-K - TIAN RUIXIANG HOLDINGS LTD (0001782941) (Filer)

    2/18/26 12:10:12 PM ET
    $TIRX
    Specialty Insurers
    Finance

    SEC Form 6-K filed by TIAN RUIXIANG Holdings Ltd

    6-K - TIAN RUIXIANG HOLDINGS LTD (0001782941) (Filer)

    2/12/26 4:30:05 PM ET
    $TIRX
    Specialty Insurers
    Finance

    SEC Form 6-K filed by TIAN RUIXIANG Holdings Ltd

    6-K - TIAN RUIXIANG HOLDINGS LTD (0001782941) (Filer)

    2/5/26 9:15:24 AM ET
    $TIRX
    Specialty Insurers
    Finance

    $TIRX
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    TIAN RUIXIANG Holdings Ltd. Announces Results of Annual General Meeting and Approval of 1-for-50 Reverse Share Split

    BEIJING, Feb. 18, 2026 (GLOBE NEWSWIRE) -- TIAN RUIXIANG Holdings Ltd. (NASDAQ:TIRX) (the "Company") today announced the results of its annual general meeting of shareholders (the "AGM") held on February 17, 2026. At the AGM, the Company's shareholders approved, among other things: 1.   An increase in the Company's authorized share capital to US$3,750,000,000; and 2.   The grant of authority to the Board of Directors to effect a reverse share split at a ratio between 1-for-2 and 1-for-5,000. Implementation of Reverse Share Split Following the AGM, the Company's Board of Directors has approved the implementation of a reverse share split of its ordinary shares at a ratio of 1-for-50 (t

    2/18/26 12:00:00 PM ET
    $TIRX
    Specialty Insurers
    Finance

    TIAN RUIXIANG Unveils unprecedented Asia-Pacific AI Healthcare Revolution: Strategic Partnership & Acquisition of Singapore's Top 3 Medical Leaders to Dominate AI-Driven Diagnostics Across Southeast Asia

    Beijing/Singapore, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Tian Ruixiang Holdings Limited ("Tianruixiang" or the "Company") (NASDAQ:TIRX), a global trailblazer in AI-powered insurance innovation, today announced a landmark expansion of its transformative ecosystem, cementing its position as the undisputed leader in AI-driven healthcare across Southeast Asia and the Asia-Pacific. Building on its historic AI initiative with top-tier global insurance firms, TIRX has entered into strategic partnership and acquisition discussions with Singapore's top three medical technology leaders, a move set to redefine the future of insurance-clinic integration and precision diagnostics in the region. The propo

    2/12/26 9:32:41 AM ET
    $TIRX
    Specialty Insurers
    Finance

    TIAN RUIXIANG Unleashes Unprecedented Asian Financial Domination: 15,000 BTC Alliance Launches Dual Assault—Historic ASEAN Stablecoin Dominance & $200 billion Australian Licensed Bank Takeover

    Beijing, Feb. 09, 2026 (GLOBE NEWSWIRE) -- TIAN RUIXIANG Holdings Ltd. (NASDAQ:TIRX) as the undisputed titan of AI-powered digital and traditional finance, the Nasdaq-listed juggernaut today detonated a seismic double-barreled plan: its game-changing 15,000 Bitcoin ("BTC") strategic alliance is not only barreling toward regulatory victory for a government-backed stablecoin empire across Southeast Asia's economic powerhouses—but is simultaneously executing a landmark, industry-redefining acquisition of a fully licensed Australian bank with a staggering $200 billion in total assets, merging crypto's revolutionary firepower with the unshakable credibility of regulated traditional banking to

    2/9/26 9:15:00 AM ET
    $TIRX
    Specialty Insurers
    Finance

    $TIRX
    Leadership Updates

    Live Leadership Updates

    View All

    TIAN RUIXIANG Holdings Ltd to Acquire Ucare Inc. in US$150 Million All-Stock Deal, Advancing In-Hospital Health Insurance Strategy

    BEIJING, May 30, 2025 (GLOBE NEWSWIRE) -- TIAN RUIXIANG Holdings Ltd (NASDAQ:TIRX) (the "Company" or "TRX"), a China-based insurance broker, today announced plans to acquire 100% of issued and outstanding shares of Ucare Inc. ("Ucare"), the sole operator of China's only cloud-based AI-driven hospital and health insurance risk management platform, in an all-share deal valued at US$150 million. This strategic move aims to unlock new growth opportunities in the health insurance segment. The Company and its wholly-owned subsidiary, VitaCare Limited ("VitaCare") have entered into a share exchange agreement (the "Agreement") with certain shareholders (the "Sellers") of Ucare and other parties.

    5/30/25 6:10:00 AM ET
    $TIRX
    Specialty Insurers
    Finance

    $TIRX
    Financials

    Live finance-specific insights

    View All

    Water Tower Research Publishes Initiation of Coverage Report on Tian Ruixiang Holdings Limited, "From Traditional Insurance Broker to Tech-Based Health Insurance Innovator"

    ST. PETERSBURG, FL, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Water Tower Research (www.watertowerresearch.com) has published an Initiation of Coverage Report on Tian Ruixiang Holdings Limited (NASDAQ:TIRX) titled, "From Traditional Insurance Broker to Tech- Based Health Insurance Innovator". The report can be accessed here. Access to China's growing health insurance market. On June 30, 2025, Chinese insurance broker Tian Ruixiang Holdings Limited completed the acquisition of Ucare, which describes itself as the only cloud-based healthcare value assessment and insurance risk control SaaS platform in China, for total all-stock consideration of $150 million. Ucare's wealth of AI-driven analytics st

    8/7/25 12:00:00 PM ET
    $TIRX
    Specialty Insurers
    Finance

    TIAN RUIXIANG Holdings Ltd Completes Acquisition of Ucare Inc., Marking Strategic Expansion into AI-Powered Health Insurance Solutions

    BEIJING, June 30, 2025 (GLOBE NEWSWIRE) -- TIAN RUIXIANG Holdings Ltd (NASDAQ:TIRX) (the "Company" or "TRX"), a China-based insurance broker, today announced it has completed the acquisition of 100% of issued and outstanding shares of Ucare Inc. ("Ucare"), the sole operator of China's only cloud-based AI-driven hospital and health insurance risk management platform. The all-stock transaction, valued at US$150 million, marks a major milestone in TRX's strategy to expand into in-hospital distribution channels and capture new growth opportunities within the health insurance sector. As part of the closing, TRX has issued 101,486,575 Class A ordinary shares, each with a par value of US$0.025

    6/30/25 3:05:00 PM ET
    $TIRX
    Specialty Insurers
    Finance

    TIAN RUIXIANG Holdings Ltd Reports Financial Results for the Half Year Ended April 30, 2024

    BEIJING, Aug. 16, 2024 (GLOBE NEWSWIRE) -- TIAN RUIXIANG Holdings Ltd (NASDAQ:TIRX) (the "Company"), a China-based insurance broker conducting business through its variable interest entity in China, today announced its financial results for the half year ended April 30, 2024. Ms. Sheng Xu, the Chief Executive Officer of the Company, commented, "The Company reported a net loss of approximately $2.6 million for the six months ended April 30, 2024, primarily due to a significant decline in revenue caused by the loss of a few key insurance company partners. However, we are encouraged by the increase in the commissions from liability insurance of approximately $24,000 compared to t

    8/16/24 4:15:15 PM ET
    $TIRX
    Specialty Insurers
    Finance

    $TIRX
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by TIAN RUIXIANG Holdings Ltd

    SC 13G/A - TIAN RUIXIANG HOLDINGS LTD (0001782941) (Subject)

    11/13/24 11:16:48 AM ET
    $TIRX
    Specialty Insurers
    Finance

    SEC Form SC 13D filed by TIAN RUIXIANG Holdings Ltd

    SC 13D - TIAN RUIXIANG HOLDINGS LTD (0001782941) (Subject)

    6/10/24 6:15:45 AM ET
    $TIRX
    Specialty Insurers
    Finance

    SEC Form SC 13D/A filed by TIAN RUIXIANG Holdings Ltd (Amendment)

    SC 13D/A - TIAN RUIXIANG HOLDINGS LTD (0001782941) (Subject)

    6/10/24 6:08:20 AM ET
    $TIRX
    Specialty Insurers
    Finance